News

Medical Marketing & Media

Portraying an Alzheimer’s patient won Julianne Moore an Oscar. Now, she leads Lilly’s brain health push.

In 2015, Julianne Moore won the Academy Award for Best Actress for her starring role in Still Alice, portraying a middle-aged woman diagnosed with early onset Alzheimer’s disease. A decade later, ...

Here's Why Novo Nordisk and Eli Lilly Could Still Be Absurdly Underrated Stocks to Buy Today

Medicare and Medicaid coverage of GLP-1 weight loss drugs could be just what the doctor ordered for these two struggling ...

Eli Lilly posts late-stage trial win for Ozempic in children and adolescents with diabetes

Eli Lilly (LLY) stock is in focus as its popular GLP-1 med Mounjaro hits main goals in a Phase 3 trial for children and ...

Eli Lilly and Company (LLY) Diabetes Medication Successful in Children and Adolescents

Eli Lilly and Co. (NYSE: LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company ...

Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

Eli Lilly said orforglipron was better at lowering blood sugar levels than Novo Nordisk's oral semaglutide, and helped ...

Novo Rises After Ozempic Beats Older Lilly Drug in Survey

Novo Nordisk A/S rose the most in a month after its diabetes blockbuster Ozempic beat Eli Lilly & Co.’s older drug Trulicity ...
STAT

Pharmalittle: We’re reading about dueling data from Lilly and Novo, a Roche deal, and much more

Novo Nordisk's diabetes blockbuster Ozempic beat Eli Lilly’s older drug Trulicity in a real-world study of certain U.S. patients ...

Lilly sees obesity drug leadership beyond US as it leans on consumer-focused strategy

Eli Lilly has established itself as the market leader in obesity drugs in Europe, Asia and the Middle East and expects to ...